Video & Transcript : 'pharmacy compounding' :
Page 31 of 222
ND
North Dakota 2025-2026 Regular Session
House Human Services Apr 9th, 2025 at 10:00 am
Human Services
Transcript Highlights:
- Number two, the aggregate amount paid to pharmacies that are owned or affiliated with the pharmacy benefit
- Number three, the aggregate amount paid to pharmacies that are not owned or affiliated with the pharmacy
- Each PBM shall disclose 340B savings for mail-order pharmacy, specialty mail-order pharmacies, and community
- Disclose the difference in 340B rates for pharmacies owned or affiliated compared to non-affiliated pharmacies
- You could have contract pharmacies, you could have FQHCs.
Summary:
The committee first addressed Senate Bill 2387, which had previously included language expanding the definition of a sexual assault victim advocate to include advocates from organizations serving victims of sexual trafficking or other sexual violence. After concerns were raised that the language could broaden participation in forensic interviews beyond appropriately credentialed organizations, the parties agreed to remove that added language. The committee then reconsidered its prior action, adopted the amendment striking the new language, and passed SB 2387 as amended on a 12-0-1 roll call vote.
The bulk of the meeting focused on Representative Nelson’s proposed changes to a 340B-related bill, centered on expanding reporting and transparency requirements. His draft would require hospitals to report how 340B savings are used, and would also add reporting by drug manufacturers, pharmacy benefit managers, and health insurers on rebates, pricing, ownership interests, 340B savings, premiums, claims, and related data. Nelson argued the reporting was needed to give lawmakers better information about how the 340B program affects hospitals, insurers, pharmacies, and public costs, and noted the Department of Corrections also benefits from the program.
Testimony was mixed but generally supportive of more transparency. Sanford Health Plan said it needed more time to review carrier impacts and had concerns about employer-related language and rebate reporting. The North Dakota Hospital Association supported hospital transparency and said the broader approach was appropriate because hospitals are only one part of the 340B system. Several members raised procedural concerns about the scope of the proposal and the lack of a drafted LC amendment. The committee decided not to take final action on the 340B proposal that day, instead forming a subcommittee led by Representative Hendricks, with Representatives Dobervich and Bolinske, to work with LC and return with drafted language for further review on Monday.
MS
Mississippi 2026 Regular Session
Public Health and Welfare - Room 216, 3 March, 2026; 3:00 PM
Public Health and Welfare
Transcript Highlights:
- . pharmacies. pharmacies.
- . pharmacies. pharmacies.
- </c> all pharmacies. all pharmacies.
- c> to</c> want the pharmacy the pharmacy board to want the pharmacy the pharmacy board to to<01:26:06.680
- </c> you know who makes up the pharmacy you know who makes up the pharmacy board?
FL
Florida 2025 Regular Session
Appropriations Committee on Health and Human Services Mar 5th, 2025
Transcript Highlights:
- THE BOARD OF PHARMACY AT THAT POINT WAS AUTHORIZED TO EXPAND THAT LIST IN COLLABORATION.
- STACY HALL, FLORIDA PHARMACY ASSOCIATION. OKAY.
- PRESIDENT AND CEO FOR FLORIDA PHARMACY ASSOCIATION.
- BOARD CERTIFICATION BUILT ON THE DOCTOR OF PHARMACY EDUCATIONAL PATHWAY COMPLETED BY ALL US PHARMACY
- PATIENT GOES TO THE PHARMACY TO GET A PRESCRIPTION, PHARMACY TELLS THE PATIENT THAT IF HE'S TAKING AN
CA
California 2025-2026 Regular Session
Assembly Business and Professions Committee Apr 8th, 2025
Transcript Highlights:
- Pharmacies are not just any other corner store or retailer.
- In pharmacies, they actually have a poor track record.
- I'm a pharmacist and pharmacy owner of 10 Acres Pharmacy here in Sacramento.
- I'm a pharmacist and pharmacy owner of 10 Acres Pharmacy here in Sacramento. So come visit me.
- Francisco when we banned the sale of tobacco from our pharmacies in 2008.
Summary:
The Assembly Business and Professions Committee heard a long agenda of licensing, health care, and workforce bills. Measures discussed included AB 957, which would prohibit tobacco sales in licensed pharmacies; AB 447, which would allow patients to take home certain unopened medications started in emergency rooms; AB 427, joining the Social Work Licensure Compact; AB 667, allowing interpreters for certain licensing exams; AB 742, prioritizing descendants of slaves in licensing review; AB 873, changing infection-control training timing for dental assistants; AB 360, requiring a report on menopause education for physicians; and AB 1175, modernizing CPA licensure requirements and mobility. Testimony generally emphasized public health, access to care, workforce shortages, language access, and economic opportunity, while opposition or concerns focused on implementation, worker protections, compact authority, and constitutional issues in AB 742.
Several bills drew broad support from sponsors, professional associations, and advocacy groups. AB 957 was backed by cancer and pharmacy advocates and pharmacists who said pharmacies should not sell tobacco; AB 447 was supported by emergency medicine and hospital representatives as a way to reduce waste and help patients leave with needed medication; AB 427 drew support from social work and mental health groups but concerns from AFSCME about standards and displacement; AB 667 was supported by immigrant-rights and community groups, with questions about whether translated exams would be preferable to interpreters; AB 360 received extensive support from women’s health advocates and medical groups, and opposition from CMA and ACOG was removed after amendments; and AB 1175 was supported by the Board of Accountancy and CPA groups as a way to expand the pipeline and improve mobility.
The committee took votes after quorum was established. AB 360, AB 427, AB 447, AB 667, AB 873, AB 1175, and AB 742 were all approved and sent to their next committees, with AB 742 going to Judiciary and AB 1175 to Appropriations. AB 957 was initially held on call, then later passed after additional votes were recorded. The consent calendar bills AB 375, AB 1107, and AB 1496 were also approved. Most measures passed on largely party-line or near-unanimous votes, with some members not voting on certain items during the roll calls.
TX
Texas 89th 2nd C.S.
89th Legislative Session - Second Called Session Aug 27th, 2025
Texas House Floor Meeting
Transcript Highlights:
- Schaffner: It's already behind the pharmacy counters.
- The Texas Board of Pharmacy takes care of their pharmacists.
- The Pharmacy Association takes care of the pharmacists.
- So if the pharmacy Board of Pharmacy says the person must complete a form verifying their weight, age
- This is not forcing a pharmacy to sell it OTC.
Keywords:
ivermectin, pharmacist authority, prescription-free, healthcare regulation, patient access, HB 48, Texas alert notification systems, emergency alerts, public warning systems, alert fatigue, notification fatigue, Texas Division of Emergency Management, Department of Public Safety, DPS alerts, emergency management, State of Texas Emergency Assistance Registry, STEAR, disaster notifications, weather alerts, Amber Alert
MN
Minnesota 2025-2026 Regular Session
Representatives Zeleznikar, Baker and Bierman Press Conference 5/12/26
Transcript Highlights:
- Pharmacies must comply with contract.
- It is every prescription that we fill in our retail pharmacy.
- </c> care, clinic services, and pharmacy care, clinic services, and pharmacy access<00:25:05.039><c>
- </c> processes of could the board of pharmacy processes of could the board of pharmacy look<00:29:31.840
- </c><00:32:06.960><c> is</c> which means more than one pharmacy is which means more than one pharmacy
Summary:
House File 369 was the main topic, with House authors Rep. Natalie Zeleznikar, Rep. Robert Bierman, and Rep. Dave Baker arguing that the bill would give Minnesota’s 2024 340B law “teeth” by enforcing protections for nonprofit and rural hospitals’ access to the federal drug pricing program. They said the measure costs the state nothing, aligns with similar laws in more than 20 other states, and is needed before adjournment to help hospitals close funding gaps, support services like emergency care, obstetrics, behavioral health, and pharmacy access, and preserve care in remote communities. Several hospital leaders from across greater Minnesota testified that 340B revenue helps keep their facilities viable and that losing it would threaten services and, in some cases, hospital survival.
Witnesses described severe financial pressure on rural hospitals, including reimbursement cuts, workforce shortages, inflation, and rising drug costs. Leaders from United Hospital District in Blue Earth, Lakewood Health System in Staples, Ely-Bloomenson Community Hospital, Northshore Health in Grand Marais, Community Memorial Hospital in Cloquet, and Cuyuna Regional Medical Center in Crosby said their hospitals serve as safety-net providers and often operate with thin or negative margins. They emphasized long travel times to other hospitals, seasonal tourism pressures in some areas, and the importance of local emergency, ambulance, inpatient, and specialty services. The Minnesota Hospital Association president also criticized pharmaceutical company messaging and said nonprofit hospitals are working around the clock to maintain access.
In response to questions, Zeleznikar said she had considered other enforcement approaches but now supported using the original Senate-passed bill, citing concerns about fraud and the difficulty of alternative enforcement mechanisms. She and hospital leaders distinguished this bill from a separate hospital stabilization-grant proposal, saying both are needed but serve different purposes. No vote was taken at the meeting, and the speakers repeatedly urged House leadership to bring the bill to the floor before session ends.
HI
Transcript Highlights:
- I would just say Walgreens is an unaffiliated pharmacy, meaning that it doesn't own or operate a PBM.
- Unaffiliated pharmacies do face the same reimbursement challenges as independent pharmacies.
- So they act as the middleman between the drug manufacturer and the end consumer, being the pharmacy or
- Earlier, HPHA, or Hawaii Pharmacy Association, okay, very much. We have read your testimony.
- </c><00:07:06.440><c> to</c> her insulin going to the pharmacy to her insulin going to the pharmacy to
Summary:
The joint hearing began with SB 59 on prescription drugs, which drew extensive testimony from insurers, pharmacies, patient advocates, and health organizations. Supporters argued the bill would address PBM practices such as spread pricing, unclear reimbursement, and patient steering, and would help independent pharmacies and lower patient costs by passing rebates through to consumers. Opponents from health plans and PBM-related groups raised concerns, while Walgreens supported the measure and suggested amendments to establish a reimbursement floor. After questions, the committee accepted the Hawaii Pharmacist Association’s proposed amendments, added technical changes and a defective date of December 31, 2050, and voted to pass SB 59 with amendments.
The remainder of the hearing focused on a series of nominations and reappointments to health, aging, disability, mental health, juvenile justice, and advisory boards. Nominees and agency representatives generally described their backgrounds and interest in serving, with support testimony emphasizing experience, continuity, and the value of volunteer service. Several nominees highlighted issues such as mental health access, substance abuse treatment, elder services, language access, disability access, and rehabilitation services. The Department of Health, SHPDA, DHS, and other organizations largely testified in support of the nominees.
No votes were taken on the nominations during the transcript excerpt, and the chair repeatedly thanked the nominees for their service and testimony. The hearing also included brief procedural remarks about time limits, Zoom testimony, and a possible reconvening date in case of technical difficulties.
KY
Kentucky 2025 Regular Session
House Standing Committee on Health Services (3-6-25)
Transcript Highlights:
- pharmacy, or a big chain pharmacy.
- pharmacy, or a big chain pharmacy.
- </c> Hawaii 58% of kuy's contract pharmacies Hawaii 58% of kuy's contract pharmacies are<01:20:35.960
- </c><01:21:30.800><c> um</c><01:21:31.520><c> some</c> Pharmacy or a big chain Pharmacy um some Pharmacy
- </c><01:22:03.560><c> map</c> we overlaid the contract Pharmacy map we overlaid the contract Pharmacy
Keywords:
00:00:00 Call to Order/Roll Call
00:01:19 Discussion of 25RS HB 785
00:30:25 Roll Call Vote on 25RS HB 785
00:32:15 Discussion of 25RS HB 61
00:36:42 Roll Call Vote on 25RS HB 61
00:38:07 Discussion of 25RS HB 788
00:51:01 Discussion of 25RS SB 14
01:11:09 Discussion of 25RS HB 685
01:44:57 Adjournment, 958, all
Summary:
The House Standing Committee on Health Services met with a quorum and took up House Bill 785, as amended by a committee substitute that combined language from HB 785 and HB 787. The bill was described as addressing Medicaid managed care organization (MCO) audits, provider contract notice and amendment procedures, mental health parity compliance, and related transparency requirements. Supporters said the measure would tighten notice to providers, limit repeated contract amendments and rate reductions, require more standardized audit procedures, and add reporting on Medicaid claims, appeals, and grievances. It also includes a provision requiring coverage of at least two evaluation-and-management billable services per physician per recipient per date of service, and a section addressing narcotic/opioid treatment program licensing and reimbursement language.
Testimony in support came from Representative Kim Moore, John Inman of BrightView Health, Michelle Sandborne of the Children’s Alliance, and Kelly Cormic of RYSE. They argued that MCOs often use audits and recoupments in ways that are burdensome, opaque, and financially damaging to providers, especially smaller and rural ones. They cited examples of multiple audit requests in short timeframes, large record requests with short deadlines, delayed or absent feedback, and recoupments taken before appeals are resolved. They also said parity laws are not being consistently enforced and that the bill would give the Department of Insurance authority to suspend or revoke an MCO certificate of authority for willful or repeated parity violations. Committee members generally expressed support for provider protections and transparency, while asking for clarification on the narcotic treatment and E/M billing provisions.
Tom Stevens of the Kentucky Association of Health Plans testified in opposition, saying the bill is complex to implement and should be handled through the broader Medicaid oversight work of House Bill 9, the MOAB. He said the issues raised were better suited for that bipartisan stakeholder process and noted the committee substitute had not yet been fully reviewed by his group. After discussion, the committee adopted the committee substitute and then moved to a vote on the bill; the roll call began, with several members recorded as voting yes, but the transcript cuts off before the final vote result is shown.
TX
Transcript Highlights:
- According to data from the Texas State Board of Pharmacy, Texas saw a net loss of one pharmacy per week
- Of the community of pharmacy across the country.
- Pharmacy benefit managers exploit their market power to strong-arm pharmacies into accepting non-negotiable
- Contracts are not accessible to the pharmacy.
- The pharmacy got the right payment, but due to a paperwork error, the pharmacy lost it all.
CA
California 2025-2026 Regular Session
Assembly Business and Professions Committee Apr 8th, 2025
Business and Professions
Transcript Highlights:
- Pharmacies are not just any other corner store or retailer.
- In pharmacies, they actually have a poor track record.
- And research suggests that a tobacco-free pharmacy law would not hurt business.
- I'm a pharmacist and pharmacy owner of 10 Acres Pharmacy here in Sacramento, so come visit me.
- Francisco when we banned the sale of. from our pharmacies in 2008 and we feel pharmacies are health
TX
Transcript Highlights:
- contracts on the pharmacy side.
- And that could be any type of pharmacy. It can be a mom-and-pop pharmacy.
- It could be a mail-order pharmacy or a specialty pharmacy.
- You're in the pharmacy business too? We do have a pharmacy, yes, sir.
- You're in the pharmacy business too? We do have a pharmacy, yes, sir.
MN
Minnesota 2025-2026 Regular Session
House Public Safety Finance and Policy Committee 3/25/25
Public Safety Finance and Policy
Transcript Highlights:
- medications requires nurses or other medical professionals to coordinate with the person's providers and pharmacy
- medications requires nurses or other medical professionals to coordinate with the person's providers and pharmacy
- medications requires nurses or other medical professionals to coordinate with the person's providers and pharmacy
- medications requires nurses or other medical professionals to coordinate with the person's providers and pharmacy
- But we want to make sure folks are at least getting the chemical compound, whatever it's branded as,
MN
Minnesota 2025-2026 Regular Session
Committee on Health and Human Services - 04/03/25
Health and Human Services
Transcript Highlights:
- and four long-term care pharmacies and a specialty pharmacy in Minnetonka Heights.
- Pharmacy. Pharmacy.
- pharmacy program.
- An annual renewal for pharmacy interns is consistent with the Board of Pharmacy standard practice, and
- It is single college of pharmacy.
AR
Arkansas 2026 Regular Session
PUBLIC HEALTH WELFARE AND LABOR COMMITTEE-SENATE AND HOUSE Jun 3rd, 2026
Transcript Highlights:
- It allows for CGMs to be billed by both pharmacy and durable medical equipment providers.
- So DME will have access to this pharmacy vendor. Will it cost them anything to have access to that?
- So my understanding, correct me if I hope, is that it's instantaneous, basically, for pharmacy.
- We're also setting up a process by which we allow the pharmacy, alert the pharmacy, that they cannot
- The whole purpose of that bill, four hours from a pharmacy store.
KY
Kentucky 2025 Regular Session
Senate Standing Committee on Health Services (2-5-25)
Transcript Highlights:
- Most rural hospitals lack in-house pharmacies, and they have to contract with local pharmacies to provide
- :43.320><c> pharmacies</c><00:10:43.920><c> to</c><00:10:44.160><c> provide</c> with local pharmacies
- </c> work collaboratively with our Pharmacy work collaboratively with our Pharmacy team<00:20:56.120>
- Prescription drugs to pharmacies contracted with a 340B covered entity.
- </c><00:37:42.200><c> are</c><00:37:42.319><c> not</c> law however pharmacies are not law however pharmacies
Keywords:
00:00 Introductions
02:46 Roll Call
03:35 Discussion on SB 14
46:13 Vote on SB 14
48:07 Discussion on SB 17
50:38 Vote on SB 17, 958, all
Summary:
The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions.
The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill.
Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.
NV
Nevada 2025 Regular Session
Assembly Committee on Commerce and Labor May 31st, 2025 at 11:30 pm
Commerce and Labor
Transcript Highlights:
- What happens from the pharmacy, you know, from the pharmacy, from the warehouse, to the patient?
- So when you went to buy them at the pharmacy, they were seeing an average savings of $500 a year.
- a pharmacy affiliated with that PBM.
- So it allows you to use your prescription, your pharmacy. Thank you.
- So it allows you to use your prescription, your pharmacy. Thank you so much.
Keywords:
public employees, police officers, benefits, appropriation, law enforcement, medical debt, collection agency, healthcare, consumer protection, financial assistance, occupational safety, air quality, greenhouse gases, employee monitoring, safety program, hemp, hemp products, cannabidiol, CBD, cannabis
KY
Kentucky 2025 Regular Session
House Standing Committee on Banking & Insurance (3-12-25)
Transcript Highlights:
- </c><00:16:41.360><c> benefit</c> insurance committee um Pharmacy benefit insurance committee um Pharmacy
- </c> artificially high prices at the pharmacy artificially high prices at the pharmacy counter<00:19:
- I was able to pull just some Anthem data from our pharmacy retail pharmacy in Campbellville for 2024.
- uh Retail Pharmacy from our uh Pharmacy uh Retail Pharmacy in<00:41:32.640><c> campbellville</c><00:
- </c> entertained a great deal of of Pharmacy entertained a great deal of of Pharmacy legislation<00:43
Keywords:
Meeting Start: 00:00
Roll Call: 00:10
SB145 Discussion: 02:23
SB145 Vote: 05:13
SB183 Discussion: 06:13
SB183 Vote: 11:37
HB413 Discussion Only: 16:15, 958, all
Summary:
The House Standing Committee on Banking and Insurance met with a quorum and first took up Senate Bill 145, sponsored by Sen. David Givens. The bill would update retail installment contract statutes for automobile sales, allowing retailers with installment contracts shorter than 28 days to begin collections after three days instead of waiting for multiple missed payments, and it also harmonizes a related dollar amount in statute from $10 to $15. The committee asked no questions, and the bill received a favorable expression on a roll-call vote.
The committee then heard Senate Bill 183 from Sen. Matt Nunn, with testimony from Chris Nolan of the American Property Casualty Insurance Association. The bill would require proxy advisers acting for the State Retirement System to act solely in the financial interest of current and future retirees and to avoid political or social considerations in shareholder voting recommendations. Supporters argued it would keep politics out of public pensions and align proxy advice with fiduciary duties; members praised the bill and noted Kentucky could be among the first states to adopt such a model. The committee approved the bill with favorable expression after a roll-call vote.
The committee also reviewed administrative regulation 808 KAR 9:10 from the Department of Financial Institutions, with no vote required. It then took up House Bill 413, a PBM rebate pass-through bill, with testimony from Sarah Wood of the Diabetes Patient Advocacy Coalition. She said the bill would require 85% of negotiated drug rebates to be passed through to patients at the point of sale, lowering out-of-pocket costs, especially for high-rebate drugs such as insulin, while still allowing 15% to remain with plans. She cited examples from other states and argued the bill would benefit about 650,000 Kentuckians. Hope McClaflin of Anthem opposed the bill, saying it would reduce employers’ ability to use rebates to lower premiums, could disproportionately favor high-cost brand-name drug users, and could create significant costs for state and fully insured plans. Members asked questions about other states’ pass-through rates and the effect on premiums, but no final action on House Bill 413 was taken in the portion of the meeting provided.
FL
Florida 2026 4th Special Session
January 27, 2026 - 03:00 PM
Transcript Highlights:
- , 1,600 pharmacies...
- , 1600 PHARMACIES 370 Closed last year.
- Chair McClure: Eric Larson, Florida Pharmacy Association, is here for information.
- My name is Eric Larson, also an independent pharmacy owner in Central Florida.
- A small town has one pharmacy, and you have an hour drive to the next one?
Summary:
The committee first took up CS/House Bill 981, which would restore the Ocklawaha River and related natural resources. Supporters, including environmental groups, Save the Manatee Club, business owners, and Reunite the Rivers advocates, argued the bill would improve manatee habitat, fish passage, flood protection, tourism, and long-term economic returns while reducing dam maintenance costs. Opponents and skeptics focused on concerns about water quality, nutrient loading in the St. Johns River, loss of the Rodman Reservoir’s habitat and water-supply value, and potential ecological and economic harms. Members in debate largely supported the restoration effort, and the bill was reported favorably on a unanimous vote.
The committee then heard HB 697, the PRICE Act, which would use international reference pricing to set a drug cost benchmark, address pharmacy benefit manager practices, and require health plans to keep drug prices stable for the year. The sponsor said the bill would lower costs and improve access, especially for uninsured Floridians. Supporters, including independent pharmacists, argued PBMs are squeezing pharmacies and that the bill could help lower prices. Opponents from BioFlorida and PhRMA warned the proposal could disrupt the national drug supply chain, fail to pass savings to patients, and lead to shortages, reduced access, and less innovation. After debate, the bill passed favorably, with Rep. Chambliss voting no.
The committee also considered CS/HB 1081, which was amended to include private colleges and universities with NCA designation in the program. After brief discussion and support from United Way Miami, the committee reported the bill favorably. Finally, CS/HB 177 was introduced as a framework for Florida’s regional councils to cross-assign bills among regions; it received supportive testimony and was also reported favorably. The meeting then adjourned.
NM
New Mexico 2025 Regular Session
IC - Water and Natural Resources Aug 20th, 2025
Water & Natural Resources Committee
Transcript Highlights:
- Additionally, we analyzed 94 volatile organic compounds.
- We also analyzed 120 semi-volatile organic compounds in the water.
- For the 84 volatile organic compounds and 120 semi-volatile organic compounds, their concentrations are
- I know NMED has a lot of studies on PFAS compounds as well.
- can remove PFAS compounds from the water.
NH
New Hampshire 2025 Regular Session
Senate Health and Human Services (02/18/2025)
Health and Human Services
Transcript Highlights:
- </c> the 340b savings um contract pharmacies the 340b savings um contract pharmacies are<02:38:09.840
- by Pharmacy pharmacies preferred by Pharmacy benefits<02:41:11.359><c> managers</c><02:41:11.960><c>
- and if so um if it isn't a pharmacy and if so um if it isn't a contract<02:51:44.000><c> Pharmacy</c
- contract Pharmacy profits goes to four contract Pharmacy profits goes to four major<02:58:09.600><c>
- We have contracts with numerous pharmacies simply because we do not operate our own pharmacy.